Effects of Breast Cancer Treatments on Cardiovascular Disease Risk Factors
A review of the results of the Pathways Heart Study, which sought to identify the link between a history of breast cancer treatment and cardiovascular risks in women.
Women’s Health
Obesity, Weight Gain in GDM Pregnancies Linked to ADHD in Offspring
Maternal obesity with excessive weight gain linked to increased risk for ADHD in offspring vs normal weight without excessive weight gain.
COVID-19 Boosters, Third Doses Well Tolerated Among Pregnant, Lactating People
Most individuals (82.8%) reported a local reaction after a COVID-19 booster or third dose, and 67.9% reported at least one systemic symptom.
FDA Panel Meeting Scheduled to Discuss Rx-to-OTC Switch of Oral Contraceptive Opill
Opill contains 0.075 mg of norgestrel, a single active steroid ingredient.
Premenstrual Mood Changes Impact Women of All Ages Globally
With increasing age, absentmindedness, low libido, sleep changes, gastrointestinal symptoms, weight gain, headaches, sweating or hot flashes, fatigue, hair changes, rashes, and swelling were significantly more frequent.
FDA Warns of Rare Cases of Certain Cancers Linked to Breast Implants
There have been fewer than 20 cases of squamous cell carcinoma and fewer than 30 cases of various lymphomas reported in the capsule around breast implants.
HPV Vaccination, Infection Rates Examined in US Women
Reduction in HPV-16/18 infection prevalence seen among a recent birth cohort of vaccinated and unvaccinated 18- to 26-year-old women.
Safety of COVID-19 mRNA Vaccines in Pregnancy Confirmed in Large Study
The rate of postvaccination health events was lower among pregnant persons than among similarly aged, nonpregnant female individuals following COVID-19 mRNA vaccinations.
Guideline for Preventing Weight Gain in Women at Midlife
Panel recommends counseling all women aged 40 to 60 years on healthy eating and physical activity to maintain weight or prevent weight gain.
Top July 2022 FDA Approvals
July 2022 FDA approvals include treatments for seizures, nonsegmental vitiligo, fecal incontinence, and ALK-positive inflammatory myofibroblastic tumor.
- Loading...
Loading...
Next post in Practice Management Information Center
Loading... 
Loading...